Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia

European Journal of Haematology

Volumn 83, Issue 4, 2009, Pages 320-327

  Eisele, Lewin ^a   Prinz, Robert ^a   Klein Hitpass, Ludger ^a   Nückel, Holger ^a   Lowinski, Kerstin ^a   Thomale, Jürgen ^a   Moeller, Lars C ^a   Dührsen, Ulrich ^a   Dürig, Jan ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

B cell chronic lymphocytic leukemia; Cryptochrome 1; Period homolog 1 (Drosophila); Period homolog 2 (Drosophila); Prognosis

Indexed keywords

CD38 ANTIGEN; CRYPTOCHROME 1; PER1 PROTEIN; PER2 PROTEIN; PROTEIN KINASE ZAP 70; RNA DIRECTED DNA POLYMERASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE; CHRONIC LYMPHATIC LEUKEMIA; CIRCADIAN RHYTHM; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE EXPRESSION; HUMAN; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; DNA REPAIR; FEMALE; FLAVOPROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KINETICS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME;

EID: 70349161927     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01287.x     Document Type: Article

References (30)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005 352 : 804 815.
2. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999 94 : 1848 1854.
3. Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001 194 : 1625 1638.
4. Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001 194 : 1639 1647.
5. Chen L, Apgar J, Huynh L, Dicker F, Giago-McGahan T, Rassenti L, Weiss A, Kipps TJ. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood 2005 105 : 2036 2041.
6. Chen L, Widhopf G, Huynh L, Rassenti L, Rai KR, Weiss A, Kipps TJ. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 2002 100 : 4609 4614.
7. Kipps TJ. The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia. Best Pract Res Clin Haematol 2007 20 : 415 424.
8. Rassenti LZ, Huynh L, Toy TL, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004 351 : 893 901.
9. Hüttmann A, Klein-Hitpass L, Thomale J, et al. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia 2006 20 : 1774 1782.
10. van der Horst GT, Muijtjens M, Kobayashi K, et al. Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature 1999 398 : 627 630.
11. Ko CH, Takahashi JS. Molecular components of the mammalian circadian clock. Hum Mol Genet 2006 15 : R271 7.
12. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002 418 : 935 941.
13. Balsalobre A. Clock genes in mammalian peripheral tissues. Cell Tissue Res 2002 309 : 193 199.
14. Boivin DB, James FO, Wu A, Cho-Park PF, Xiong H, Sun ZS. Circadian clock genes oscillate in human peripheral blood mononuclear cells. Blood 2003 102 : 4143 4145.
15. Fukuya H, Emoto N, Nonaka H, Yagita K, Okamura H, Yokoyama M. Circadian expression of clock genes in human peripheral leukocytes. Biochem Biophys Res Commun 2007 354 : 924 928.
16. Kusanagi H, Mishima K, Satoh K, Echizenya M, Katoh T, Shimizu T. Similar profiles in human period1 gene expression in peripheral mononuclear and polymorphonuclear cells. Neurosci Lett 2004 365 : 124 127.
17. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002 111 : 41 50.
18. Gery S, Koeffler HP. The role of circadian regulation in cancer. Cold Spring Harb Symp Quant Biol 2007 72 : 459 464.
19. Lin YM, Chang JH, Yeh KT, Yang MY, Liu TC, Lin SF, Su WW, Chang JG. Disturbance of circadian gene expression in hepatocellular carcinoma. Mol Carcinog 2008 47 : 925 933.
20. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 2005 26 : 1241 1246.
21. Tokunaga H, Takebayashi Y, Utsunomiya H, Akahira J, Higashimoto M, Mashiko M, Ito K, Niikura H, Takenoshita S, Yaegashi N. Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer. Acta Obstet Gynecol Scand 2008 87 : 1060 1070.
22. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996 87 : 4990 4997.
23. Schroers R, Griesinger F, Trümper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Dührsen U, Dürig J. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 2005 19 : 750 758.
24. Haslinger C, Schweifer N, Stilgenbauer S, Dohner H, Lichter P, Kraut N, Stratowa C, Abseher R. Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status. J Clin Oncol 2004 22 : 3937 3949.
25. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003 4 : 249 264.
26. Nelson W, Tong YL, Lee JK, Halberg F. Methods for cosinor-rhythmometry. Chronobiologia 1979 6 : 305 323.
27. Langmesser S, Tallone T, Bordon A, Rusconi S, Albrecht U. Interaction of circadian clock proteins PER2 and CRY with BMAL1 and CLOCK. BMC Mol Biol 2008 9 : 41.
28. Yang MY, Chang JG, Lin PM, Tang KP, Chen YH, Lin HY, Liu TC, Hsiao HH, Liu YC, Lin SF. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci 2006 97 : 1298 1307.
29. Shih MC, Yeh KT, Tang KP, Chen JC, Chang JG. Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR. Mol Carcinog 2006 45 : 732 740.
30. Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP. Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. Blood 2005 106 : 2827 2836.